Newsweek magazine may be in trouble, but its annual green rankings are one of the most comprehensive attempts to rank major companies based on sustainability. How does your company measure up?READ»
In the third post of their 7-part series, John Elkington and Charmian Love look at how CEOs are coping with the new wild cards dealt by environmental, social and governance challenges.READ»
Debbie Weil is known as the corporate blogging expert, and though she's no doubt earned the title -- she's worked for clients including GlaxoSmithKline and the American College of Radiology -- she can't help but find humor in the name.READ»
You're probably among the millions who have experienced it: driving in a car, listening to the radio, and suddenly this song comes on. It is not just any song--this was your favorite song when you were a teenager. As the first few ...READ»
Outsourcing means jobs go overseas, right? Not always. At this
Orlando summit, Monty Hamilton, CEO of Atlanta-based Rural Sourcing,
will explain how U.S. firms can save by moving work to the South. Rural
Sourcing has centers in ...READ»
The safety of drugs these days is a major issue not only with patients, but in the legal arena as med mal attorneys fight for justice for victims.
READ»
Why do you work? As we emerge from the rubble of the Great Recession, more people from a variety of sectors and in different stages of life are searching for a more meaningful “why” behind the work they do. Paying the bills ...READ»
When the human genome was first sequenced nearly a decade ago, the world lit up with talk about how new gene-specific drugs would help us cheat death. Well, the verdict is in: Keep eating those greens.READ»
Whole books have been written about market segmentation, so it is difficult to summarize it on a page. One of the leading segmentation methodologies, that became part of teaching at the Harvard Business School, is what we lived ...READ»
Four years ago, the startup Nabi Biopharmaceuticals began testing a promising nicotine vaccine called NicVax with the aid of $4.1 million in funding from the National Institutes of Health. Earlier today, the vaccine received a booster ...READ»
Last week will go down as a truly significant week in health care reform. The House leadership unveiled its 1,000+ page bill and announced that the three committees of jurisdiction would immediately begin mark-up sessions designed to get a composite bill to the House floor by the end of July. Late last week the House Ways and Means Committee approved the House bill 23 to 18READ»
Malaria kills one million people a year, most of them children in Africa's so-called Malaria Belt (the sub-Saharan region). In partnership with the Gates Foundation, pharmaceuticals giant GlaxoSmithKline is preparing an ambitious ...READ»
Fifteen years after the genocide, the small African country has embraced a new model of economic development. Its strategy: Build a global network of powerful friends to lure private investment -- and market the brand of Rwanda.READ»
It seems that I spend a great deal of time these days talking about the subconcious emotional drivers of designs. It turns out that there are very good reasons we all "buy" what we do. Reasons that are tied into our biology, ...READ»
Do you help your employees find the work they love to do? It may not always be easy, and you may even risk losing some of them. But if you don’t partner with your talented employees to find work they are passionate about, you will no doubt lose them anyway.READ»
In the super-regulated world of pharmaceuticals, some of the world’s largest corporations are using digital media to get closer to customers and advocates. GlaxoSmithKline and Johnson & Johnson are using blogs to engage in ...READ»
Path (Program for Appropriate Technology in Health)
Founded: 1977 Seattle, Washington Christopher J. Elias, President www.path.org
Entrepreneurship: A
Innovation: A+
Social Impact: A+
Aspiration: A-
Sustainability: A- ...READ»
How does a giant pharmaceutical company reckon with genomics technology? By making a fresh start in how it recruits its scientists, manages projects, and uses computers. Here's how the Roche Group is reinventing how it invents.READ»